Simona Dalin
Affiliations: | Broad Institute (MIT/Harvard) |
Area:
Cancer biology, chemotherapy resistance, genomicsGoogle:
"Simona Dalin"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Michael T. Hemann | grad student | 2014-2019 | (Telomere and Telomerase Tree) |
| Doug A. Lauffenburger | grad student | 2014-2019 | (Chemistry Tree) |
| Rameen Beroukhim | post-doc | 2019- |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chukwu W, Lee S, Crane A, et al. (2023) Genomic sequence context differs between germline and somatic structural variants allowing for their differentiation in tumor samples without paired normals. Biorxiv : the Preprint Server For Biology |
| Dalin S, Webster S, Sugawara N, et al. (2023) Double-strand break repair-associated intragenic deletions and tandem duplications suggest the architecture of the repair replication fork. Biorxiv : the Preprint Server For Biology |
| Dalin S, Grauman-Boss B, Lauffenburger DA, et al. (2022) Collateral responses to classical cytotoxic chemotherapies are heterogeneous and sensitivities are sparse. Scientific Reports. 12: 5453 |
| Mueller HS, Fowler CE, Dalin S, et al. (2021) Acquired resistance to PRMT5 inhibition induces concomitant collateral sensitivity to paclitaxel. Proceedings of the National Academy of Sciences of the United States of America. 118 |
| Dalin S, Sullivan MR, Lau AN, et al. (2019) Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance. Cancer Research |
| Dalin S, Zhao B, Hemann MT. (2017) Abstract PR07: Collateral sensitivity in chemotherapy resistance Molecular Cancer Therapeutics. 16 |
| Sun D, Dalin S, Hemann MT, et al. (2016) Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations. Scientific Reports. 6: 36198 |
| Wilson JL, Dalin S, Gosline S, et al. (2016) Pathway-based network modeling finds hidden genes in shRNA screen for regulators of acute lymphoblastic leukemia. Integrative Biology : Quantitative Biosciences From Nano to Macro |
| Dalin S, Zhao B, Hemann MT. (2016) Abstract 35: Evolution of resistance to glucocorticoid receptor agonists Clinical Cancer Research. 22: 35-35 |